We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Western Alliance Bancorporation
WAL
$9.07B
| $3.05M | 0.05% |
+123,850
| New | +$2.87M |
|
327
Koppers
KOP
$966M
| $3.04M | 0.05% |
73,646
+25,490
| +53% | +$1.04M |
|
328
Insight Enterprises
NSIT
$3.55B
| $3.02M | 0.05% |
120,279
+61,519
| +105% | +$1.42M |
|
|
TBI
329
Trueblue
TBI
$234M
| $3.02M | 0.05% |
103,030
-125,200
| -55% | -$3.36M |
|
330
United Rentals
URI
$71.1B
| $3.01M | 0.05% |
+31,700
| New | +$2.69M |
|
331
Albany International
AIN
$2.14B
| $3.01M | 0.05% |
84,604
-2,300
| -3% | -$82K |
|
332
Enviri
NVRI
$621M
| $2.98M | 0.05% |
127,150
-130,274
| -51% | -$3.2M |
|
333
Comtech Telecommunications
CMTL
$51.8M
| $2.95M | 0.05% |
92,715
-6,820
| -7% | -$215K |
|
334
MBIA
MBI
$288M
| $2.95M | 0.05% |
+211,160
| New | +$2.69M |
|
335
Incyte
INCY
$23.5B
| $2.94M | 0.05% |
+54,870
| New | +$3.41M |
|
|
EGL
336
DELISTED
Engility Holdings, Inc.
EGL
| $2.93M | 0.05% |
65,000
-19,700
| -23% | -$810K |
|
|
PMC
337
DELISTED
PharMerica Corporation
PMC
| $2.88M | 0.05% |
103,029
+25,700
| +33% | +$631K |
|
338
Hawaiian Electric Industries
HE
$2.33B
| $2.85M | 0.05% |
+111,975
| New | +$2.86M |
|
339
Interparfums
IPAR
$3.92B
| $2.81M | 0.05% |
77,489
-2,500
| -3% | -$84K |
|
|
PDCE
340
DELISTED
PDC Energy, Inc.
PDCE
| $2.78M | 0.05% |
+44,690
| New | +$2.45M |
|
|
IM
341
DELISTED
Ingram Micro
IM
| $2.76M | 0.05% |
93,480
+54,730
| +141% | +$1.47M |
|
342
Blackrock
BLK
$164B
| $2.75M | 0.05% |
8,756
+112
| +1% | +$34.2K |
|
343
Modine Manufacturing
MOD
$12.8B
| $2.75M | 0.05% |
187,428
+33,839
| +22% | +$466K |
|
|
CSOD
344
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $2.73M | 0.05% |
57,010
+23,610
| +71% | +$1.32M |
|
|
VRNT
345
DELISTED
Verint Systems
VRNT
| $2.72M | 0.05% |
113,832
+66,402
| +140% | +$1.56M |
|
|
CIR
346
DELISTED
CIRCOR International, Inc
CIR
| $2.72M | 0.05% |
37,073
+8,960
| +32% | +$669K |
|
|
SBNY
347
DELISTED
Signature Bank
SBNY
| $2.72M | 0.05% |
21,636
+6,056
| +39% | +$740K |
|
|
PVTB
348
DELISTED
PrivateBancorp Inc
PVTB
| $2.71M | 0.05% |
88,960
-2,280
| -2% | -$66.1K |
|
|
SEM
349
DELISTED
Select Medical
SEM
| $2.7M | 0.05% |
+401,843
| New | +$2.44M |
|
350
Global Payments
GPN
$22.1B
| $2.69M | 0.05% |
75,740
+69,200
| +1,058% | +$2.38M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.